Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Syncona Share News (SYNC)
SYNC Share
Price
SYNC Share
News
SYNC Share
Chat
SYNC Share
Trades38
SYNC
Live RNS
SYNC Share
Charts
SYNC Level 2
Console
SYNC Live
Share Price
SYNC Broker
Ratings
SYNC Directors
Deals
SYNC Financial
Diary
SYNC
Fundamentals
SYNC Short
Positions
SYNC
Media
SYNC Company
Research
SYNC Company
Timeline
Share Price Information for Syncona (SYNC)
Last checked at -
Last checked at 
Intraday Syncona Share Chart
Syncona News
Syncona investee Achilles plans liquidation and capital return
(Alliance News) - Syncona Ltd on Wednesday said portfolio company Achilles Therapeutics PLC is planning to return capital to shareholders though a mem...
London close: Stocks mixed in quiet post-Christmas trade
(Sharecast News) - London markets closed on a mixed note Friday in subdued trading, as the ongoing holiday period kept activity light with little news...
LONDON MARKET MIDDAY: Stocks red ahead of US trade balance read
(Alliance News) - Stock prices in London were mostly lower at midday on Friday as market participants continue digesting US jobless data and unrest in...
Syncona investee sells assets to AstraZeneca for USD12 million
(Alliance News) - Syncona Ltd on Friday said one of its investments Achilles Therapeutics PLC has sold its technology assets to AstraZeneca PLC for US...
LONDON BRIEFING: Stocks seen down as holiday sales stabilise
(Alliance News) - The FTSE 100 index in London was called slightly lower on Friday, as investors digest holiday-season sales results in the US and UK.
Syncona investment sells cancer study assets to AstraZeneca for $12m
(Sharecast News) - Life science investor Syncona said its investment Achilles Therapeutics has sold cancer study assets to AstraZeneca for $12m (£...
Syncona hails positive trial data for new Beacon Therapeutics drug
(Alliance News) - Syncona Ltd on Friday reported promising trial results for the drug laru-zova, the lead asset of Syncona subsidiary Beacon Therapeut...
Syncona upbeat on interim trial results at Beacon Therapeutics
(Sharecast News) - Syncona announced positive three-month interim results from the phase two 'DAWN' trial conducted by its portfolio company Beacon Th...
Follow the stocks
